|
Home Page >
Pharmaceutical
Litigation > Vioxx
Vioxx Settlement Agreed Upon by Merck
November 9, 2007
Merck Pharmaceutical company, maker of Vioxx (rofecoxib), has agreed to settle 27,000 personal injury lawsuits for $4.85 Billion brought forth by people that have been injured or died after taking Vioxx. This deal, supported by judges in Louisiana, New Jersey and California, is not written in stone yet as it must be agreed upon by 85% or more of the plaintiffs involved. If this Vioxx settlement is reached, it could be one of the largest in history.
To receive settlements, plaintiffs will not be required to prove that Vioxx caused their heart attacks or strokes. But they, or their families, will have to provide evidence that they did suffer a heart attack or stroke, that the heart attack or stroke occurred less than 14 days after they last took Vioxx, and that they had taken Vioxx for at least 30 days. People who took Vioxx for longer, who had fewer other risk factors, and who suffered more severe problems will receive larger payments than people who meet only the minimum criteria.
The FDA announced on September 28, 2004, the voluntary
recall of the COX-2 inhibitor rofecoxib, Vioxx by Merck &
Co. Inc.
Vioxx was approved by the Food and Drug
Administration in 1999 for the management of acute pain related
to arthritis and menstrual symptoms. After extensive studies
conducted by Merck & Co. Inc, it was determined that patients
using Vioxx showed an increased risk of heart attacks, strokes,
and other cardiovascular events.
The Oklahoma City based plaintiff's personal injury law firm
of Atkins & Markoff has handled numerous defective drug
claims and lawsuits including Fen-Phen (fenfluramine, phentermine,
dexenfluramine) and Baycol (cerivastatin).
If you or a loved on has been injured due to the side effects
of the recalled COX-2 inhibitor Vioxx, contact
us today.
|
